We also examined the effects of combining IDH2 inhibition with cisplatin or radiation for the treatment of lung cancer and explored the mechanisms underlying the combination effect, with a focus on the impact of IDH2 abrogation on mitochondrial metabolism and ROS generation. The gene discussed is IDH2; the disease is lung carcinoma.